Pantoprazolo Accord Healthcare (Pantoprazole Sodium Sesquihydrate)

Pantoprazole Sodium Sesquihydrate, the active ingredient in Pantoprazolo Accord Healthcare, is a proton pump inhibitor presented as a tablet for oral use. It treats acid‑related disorders such as gastro‑oesophageal reflux disease and is prescribed for adults who require reduction of gastric acid secretion.

GNH USA supplies Pantoprazolo Accord Healthcare as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazolo Accord Healthcare is a proton pump inhibitor that acts on conditions driven by excess gastric acid production. - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Erosive esophagitis: facilitates mucosal healing and reduces further acid injury. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumours. - Prevention of NSAID‑induced gastric ulcers: lowers the risk of ulcer formation in patients receiving chronic non‑steroidal anti‑inflammatory therapy.

Pantoprazolo Accord Healthcare is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: occasional mild episodes. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, difficulty breathing. - Clostridioides difficile infection: persistent watery diarrhoea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat. - Acute interstitial nephritis: kidney inflammation presenting with reduced urine output. - Fracture risk with long‑term use: decreased bone mineral density.

When prescribing Pantoprazolo Accord Healthcare, clinicians should consider several safety aspects. - Assess renal and hepatic function: dose adjustment may be required in severe impairment. - Review concomitant medications: potential for drug‑drug interactions. - Monitor long‑term users: consider bone health and magnesium levels. - Use with caution in pregnancy: weigh benefits against potential risks. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Pantoprazolo Accord Healthcare can affect the plasma concentrations of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole and itraconazole: reduced antifungal absorption. - Atazanavir and nelfinavir: markedly decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, monitor coagulation. - Digoxin: slight increase in serum levels, observe for toxicity. - Methotrexate: reduced renal clearance, watch for accumulation. - Clopidogrel: diminished antiplatelet effect, consider alternative therapy.